Guardant Health, Inc.
GHFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
739
Cost of Revenue
290
Gross Profit
449
Gross Margin
60.8%
Operating Income
-444
Operating Margin
-60.0%
Net Income
-436
Net Margin
-59.0%
EPS (Basic)
$-3.56
EPS (Diluted)
$-3.56
EBITDA
-390
EBITDA Margin
-52.8%
2023
12/31/2023
Revenue
564
Cost of Revenue
227
Gross Profit
337
Gross Margin
59.7%
Operating Income
-565
Operating Margin
-100.1%
Net Income
-479
Net Margin
-85.0%
EPS (Basic)
$-4.28
EPS (Diluted)
$-4.28
EBITDA
-433
EBITDA Margin
-76.8%
2022
12/31/2022
Revenue
450
Cost of Revenue
156
Gross Profit
293
Gross Margin
65.2%
Operating Income
-544
Operating Margin
-121.1%
Net Income
-655
Net Margin
-145.6%
EPS (Basic)
$-6.41
EPS (Diluted)
$-6.41
EBITDA
-615
EBITDA Margin
-136.8%
2021
12/31/2021
Revenue
374
Cost of Revenue
123
Gross Profit
251
Gross Margin
67.1%
Operating Income
-411
Operating Margin
-110.0%
Net Income
-406
Net Margin
-108.6%
EPS (Basic)
$-3.80
EPS (Diluted)
$-3.80
EBITDA
-360
EBITDA Margin
-96.2%
2020
12/31/2020
Revenue
287
Cost of Revenue
93
Gross Profit
194
Gross Margin
67.7%
Operating Income
-255
Operating Margin
-88.9%
Net Income
-254
Net Margin
-88.5%
EPS (Basic)
$-2.53
EPS (Diluted)
$-2.53
EBITDA
-225
EBITDA Margin
-78.5%